Next Article in Journal
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients
Previous Article in Journal
Diagnostic and Therapeutic Challenges of Cerebral Venous Thrombosis in SARS-CoV-2 Infection: A Case Report and Review of Literature
Article

Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool

1
Pain in Motion Research Group (PAIN), Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, 1050 Brussel, Belgium
2
Institut de Formation en Masso-Kinésithérapie de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France
3
Interfaculty Center for Data Processing and Statistics, Core Facility, Vrije Universiteit Brussel, 1050 Brussel, Belgium
4
Biostatistics and Medical Informatics Research Group, Faculty of Medicine and Pharmacy, Department of Public Health, Vrije Universiteit Brussel, 1050 Brussel, Belgium
5
Breederode Hogeschool, 3011 Rotterdam, The Netherlands
6
Centre d’Evaluation et de Traitement de la Douleur, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
7
Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives, 67000 Strasbourg, France
8
Chronic Pain Rehabilitation, Department of Physical Medicine and Physiotherapy, University Hospital Brussels, 1090 Jette, Belgium
9
Unit of Physiotherapy, Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden
10
Center for Person-Centred Care (GPCC), Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden
*
Authors to whom correspondence should be addressed.
Academic Editor: Maurizio Aricò
Clin. Pract. 2021, 11(3), 607-618; https://doi.org/10.3390/clinpract11030076
Received: 30 June 2021 / Revised: 18 August 2021 / Accepted: 31 August 2021 / Published: 7 September 2021
The Central Sensitization Inventory (CSI) measurement properties in patients having nonspecific, noncancer pain are well-established. However, studies examining the reliability and validity of either the CSI or the Central Sensitization Inventory short-form version (CSI-9) in breast cancer survivors (BCS) are scarce. The purpose was to evaluate convergent validity and internal consistency of the CSI and CSI-9. Additionally, the relevance of a new cluster calculator using the CSI was explored. The cross-sectional multi-center study included 65 BCS and 37 healthy volunteers. Patients filled out multiple questionnaires assessing pain, number of painful areas, anxiety, depression and quality of life. The relevance of a cluster calculator was explored by known-group comparisons and boxplot description. All hypotheses were formulated before data analysis. The majority of hypotheses on the correlations between the CSI or CSI-9 and other health outcomes were confirmed (22 out of 27). The CSI and CSI-9 have excellent (α = 0.92) and good (α = 0.86) internal consistency, respectively. The CSI cluster calculator might be an interesting tool to use to have a patient’s overall condition snapshot. Generally, the study findings support the construct validity and internal consistency of the CSI, which underline the use of this self-reported instrument in BCS. The CSI-9 shows promising results, but should be further evaluated. View Full-Text
Keywords: breast cancer; cancer survivors; chronic pain; central sensitization; central sensitivity syndrome; central sensitization inventory breast cancer; cancer survivors; chronic pain; central sensitization; central sensitivity syndrome; central sensitization inventory
MDPI and ACS Style

Hurth, A.; Nijzink-Ter Steege, J.; Scheepbouwer, P.; Roose, E.; Lahousse, A.; Leysen, L.; Stas, L.; Kregel, J.; Salvat, E.; Nijs, J. Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool. Clin. Pract. 2021, 11, 607-618. https://doi.org/10.3390/clinpract11030076

AMA Style

Hurth A, Nijzink-Ter Steege J, Scheepbouwer P, Roose E, Lahousse A, Leysen L, Stas L, Kregel J, Salvat E, Nijs J. Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool. Clinics and Practice. 2021; 11(3):607-618. https://doi.org/10.3390/clinpract11030076

Chicago/Turabian Style

Hurth, Alban, Jessica Nijzink-Ter Steege, Pauline Scheepbouwer, Eva Roose, Astrid Lahousse, Laurence Leysen, Lara Stas, Jeroen Kregel, Eric Salvat, and Jo Nijs. 2021. "Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool" Clinics and Practice 11, no. 3: 607-618. https://doi.org/10.3390/clinpract11030076

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop